For example, high expression of IGF2BP3 is associated with a proliferative phenotype of pediatric B-cell acute lymphoblastic leukemia (B-ALL) at the mRNA and protein levels and portends favorable survival in high-risk B-ALL patients (Mäkinen et al., 2021). This evidence concerns the gene IGF2BP3 and precursor B-cell acute lymphoblastic leukemia.